Related Experiment Video
Updated: Sep 25, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
DPP4 Promotes Human Endothelial Cell Senescence and Dysfunction via the PAR2-COX-2-TP Axis and NLRP3 Inflammasome
Inés Valencia1,2,3, Susana Vallejo1,3, Pilar Dongil1,3
1Department of Pharmacology and Therapeutics, School of Medicine (I.V., S.V., P.D., A.R., Á.S.H.-L., L.S., T.R., C.P., C.F.S.-F.), Universidad Autónoma de Madrid, Spain.
Background:
Abnormal accumulation of senescent cells in the vessel wall leads to a compromised vascular function contributing to vascular aging. Soluble DPP4 (dipeptidyl peptidase 4; sDPP4) secretion from visceral adipose tissue is enhanced in obesity, now considered a progeric condition. sDPP4 triggers vascular deleterious effects, albeit its contribution to vascular aging is unknown. We aimed to explore sDPP4 involvement in vascular aging, unraveling the molecular pathway by which sDPP4 acts on the endothelium.
Methods:
Human endothelial cell senescence was assessed by senescence-associated β-galactosidase assay, visualization of DNA damage, and expression of prosenescent markers, whereas vascular function was evaluated by myography over human dissected microvessels. In visceral adipose tissue biopsies from a cohort of obese patients, we explored several age-related parameters in vitro and ex vivo.
Results:
By a common mechanism, sDPP4 triggers endothelial cell senescence and endothelial dysfunction in isolated human resistance arteries. sDPP4 activates the metabotropic receptor PAR2 (protease-activated receptor 2), COX-2 (cyclooxygenase 2) activity, and the production of TXA2 (thromboxane A2) acting over TP (thromboxane receptor) receptors (PAR2-COX-2-TP axis), leading to NLRP3 (nucleotide-binding oligomerization domain, leucine-rich repeat, and pyrin domain-containing 3) inflammasome activation. Obese patients exhibited impaired microarterial functionality in comparison to control nonobese counterparts. Importantly, endothelial dysfunction in obese patients positively correlated with greater expression of DPP4, prosenescent, and proinflammatory markers in visceral adipose tissue nearby the resistance arteries. Moreover, when DPP4 activity or sDPP4-induced prosenescent mechanism was blocked, endothelial dysfunction was restored back to levels of healthy subjects.
Conclusions:
These results reveal sDPP4 as a relevant mediator in early vascular aging and highlight its capacity activating main proinflammatory mediators in the endothelium that might be pharmacologically tackled.
Insights
Soluble DPP4 (dipeptidyl peptidase 4) accelerates vascular aging by promoting endothelial cell senescence and dysfunction. Blocking DPP4 activity restores vascular function, suggesting it as a therapeutic target for age-related vascular decline.
Area of Science:
- Vascular Biology
- Cellular Senescence
- Obesity Research
Background:
- Vascular aging is linked to senescent cell accumulation in vessel walls.
- Obesity, a progeric condition, increases soluble DPP4 (dipeptidyl peptidase 4) secretion.
- The role of sDPP4 in vascular aging and its endothelial mechanisms remain unexplored.
Purpose of the Study:
- To investigate the involvement of sDPP4 in vascular aging.
- To elucidate the molecular pathways through which sDPP4 affects the endothelium.
Main Methods:
- Assessed endothelial cell senescence using senescence markers and DNA damage assays.
- Evaluated vascular function in human microvessels via myography.
- Analyzed age-related parameters in visceral adipose tissue from obese patients.
Main Results:
- sDPP4 induces endothelial senescence and dysfunction via the PAR2-COX-2-TP axis, activating the NLRP3 inflammasome.
- Obese patients show impaired microarterial function, correlating with elevated DPP4 and pro-inflammatory markers.
- Inhibition of DPP4 activity or sDPP4-induced senescence reversed endothelial dysfunction.
Conclusions:
- sDPP4 is a key mediator in early vascular aging.
- sDPP4 activates pro-inflammatory pathways in the endothelium.
- Targeting sDPP4 offers a potential therapeutic strategy for vascular aging.
Related Concept Videos
Peripheral Artery Disease I: Introduction
The Extrinsic Apoptotic Pathway
IP3/DAG Signaling Pathway
Paracrine Signaling
The Intrinsic Apoptotic Pathway
Abnormal Proliferation

